These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6302659)

  • 1. The association of amyloid P-component (AP) with the amyloid fibril: an updated method for amyloid fibril protein isolation.
    Skinner M; Shirahama T; Cohen AS; Deal CL
    Prep Biochem; 1982; 12(5):461-76. PubMed ID: 6302659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the association between amyloid fibrils and glycosaminoglycans; possible interactive role of Ca2+ and amyloid P-component.
    Stenstad T; Magnus JH; Syse K; Husby G
    Clin Exp Immunol; 1993 Oct; 94(1):189-95. PubMed ID: 8403505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Widespread occurrence of AP in amyloidotic tissues. An immunohistochemical observation.
    Shirahama T; Skinner M; Sipe JD; Cohen AS
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1985; 48(3):197-206. PubMed ID: 2859693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The amyloid P-component (protein AP): an integral part of the amyloid substance?
    Holck M; Husby G; Sletten K; Natvig JB
    Scand J Immunol; 1979; 10(1):55-60. PubMed ID: 472666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosaminoglycans of the hemodialysis-associated carpal synovial amyloid and of amyloid-rich tissues and fibrils of heart, liver, and spleen.
    Ohishi H; Skinner M; Sato-Araki N; Okuyama T; Gejyo F; Kimura A; Cohen AS; Schmid K
    Clin Chem; 1990 Jan; 36(1):88-91. PubMed ID: 2297939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of P-component (AP) isolated from amyloidotic tissue: half-life studies of human and murine AP.
    Skinner M; Sipe JD; Yood RA; Shirahama T; Cohen AS
    Ann N Y Acad Sci; 1982; 389():190-8. PubMed ID: 6953915
    [No Abstract]   [Full Text] [Related]  

  • 7. Amyloid fibril protein in type I familial amyloidotic polyneuropathy in Japanese.
    Tawara S; Araki S; Toshimori K; Nakagawa H; Ohtaki S
    J Lab Clin Med; 1981 Dec; 98(6):811-22. PubMed ID: 7310224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A high resolution ultrastructural study of experimental murine AA amyloid.
    Inoue S; Kisilevsky R
    Lab Invest; 1996 Mar; 74(3):670-83. PubMed ID: 8600318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A close ultrastructural relationship between sulfated proteoglycans and AA amyloid fibrils.
    Snow AD; Willmer J; Kisilevsky R
    Lab Invest; 1987 Dec; 57(6):687-98. PubMed ID: 2447384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review: history of the amyloid fibril.
    Sipe JD; Cohen AS
    J Struct Biol; 2000 Jun; 130(2-3):88-98. PubMed ID: 10940217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of serum amyloid P-component (SAP) by amyloid fibrils.
    Pepys MB; Dyck RF; de Beer FC; Skinner M; Cohen AS
    Clin Exp Immunol; 1979 Nov; 38(2):284-93. PubMed ID: 118839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of amyloid fibrils from tissue.
    Tennent GA
    Methods Enzymol; 1999; 309():26-47. PubMed ID: 10507014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies of the high molecular weight amyloid fibril proteins and similar components from normal tissues.
    Scott DL; Marhaug G; Husby G
    Clin Exp Immunol; 1983 Jun; 52(3):693-701. PubMed ID: 6409474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of a low-molecular-weight serum component antigenically related to an amyloid fibril protein of unknown origin.
    Linke RP; Sipe JD; Pollock PS; Ignaczak TF; Glenner GG
    Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1473-6. PubMed ID: 805429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of amyloid deposits and P component from a patient with factor X deficiency reveals proteins derived from a lambda VI light chain.
    Cohen D; Pras M; Franklin EC; Frangione B
    Am J Med; 1983 Mar; 74(3):513-8. PubMed ID: 6402931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific chemical dissociation of fibrillar and non-fibrillar components of amyloid deposits.
    Hind CR; Collins PM; Caspi D; Baltz ML; Pepys MB
    Lancet; 1984 Aug; 2(8399):376-8. PubMed ID: 6147456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human amyloid P component: an elastase inhibitor.
    Li JJ; McAdam KP
    Scand J Immunol; 1984 Sep; 20(3):219-26. PubMed ID: 6568019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical, chemical, and ultrastructural studies of water-soluble human amyloid fibrils. Comparative analyses of nine amyloid preparations.
    Pras M; Zucker-Franklin D; Rimon A; Franklin EC
    J Exp Med; 1969 Oct; 130(4):777-96. PubMed ID: 5343433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quaternary structure of murine amyloid fibrils: fibril dissociation following exposure to sodium dodecyl sulfate and alkali].
    Bannikova EM; Sura VV
    Biull Eksp Biol Med; 1980 May; 89(5):546-8. PubMed ID: 7397334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural immunohistochemical localization of polyclonal IgG, C3, and amyloid P component on the congo red-negative amyloid-like fibrils of fibrillary glomerulopathy.
    Yang GC; Nieto R; Stachura I; Gallo GR
    Am J Pathol; 1992 Aug; 141(2):409-19. PubMed ID: 1497092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.